LA
AEON.WS

Linden Advisors’s AEON Biopharma Inc AEON.WS Stock Holding History

Linden Advisors’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-200,000
Closed -$204K – 687
2021
Q2 		$204K Buy
+200,000
New +$152K ﹤0.01% 685

Other funds holding AEON.WS

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Linden Advisors's AEON.WS Position: Q3 2021 in Review

Linden Advisors sold out of AEON Biopharma Inc (AEON.WS) in Q3 2021, closing a stake of 200,000 shares — an estimated $204K sold.

Linden Advisors first reported a position in AEON.WS in Q2 2021 and held it in 1 quarter. The position peaked at $204K in Q2 2021. 48 funds tracked by Wall St. Rank hold AEON.WS as of Q3 2021.

  • Linden Advisors reported no remaining AEON Biopharma Inc position as of Q3 2021 after selling out during the quarter.
  • Linden Advisors sold 200,000 AEON Biopharma Inc shares in Q3 2021, an estimated $204K.
  • Linden Advisors first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 1 quarter.
  • Linden Advisors's AEON Biopharma Inc position peaked at $204K in Q2 2021.
  • 48 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q3 2021.

Based on Linden Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.